Allocations
Product development firm Cambridge Consultants, part of the Altran group, is to acquire Synapse.
The acquisition will allow for the combined firms to create one of the world’s largest product development companies with significant presence on both coasts of the US. This acquisition, combined with Cambridge Consultants, will grow the Innovative Product Development activity revenues of Altran by 50 per cent by the end of 2016 (on a proforma basis), and fits within Altran’s ‘2020 Ignition’ strategic plan under which Cambridge Consultants is aiming to double its scale and enhance its geographic reach in the US and Asia.
From its
BlackRock Real Assets has entered into an agreement to purchase GE Energy Financial Services’ 50 per cent interest in the Grandview wind project (Grandview).
Grandview is now jointly owned by BlackRock and E.ON Climate and Renewables North America (EC&RNA), a subsidiary of E.ON SE, one of the world’s largest renewable power providers.
Grandview has been operating since December, 2014 and is located on 45,000 acres in Carson County, Texas in the ERCOT regional transmission origination system. The 211 MW wind project will supply electricity to the region under a long-term offtake agreement with an investment grade counterparty and utilises proven,
Law firm, Mourant Ozannes, has advised 3i Infrastructure on the successful completion of a capital raise with gross proceeds of GBP385 million.
3i Infrastructure plc is a FTSE 250 infrastructure investment company. Capital raised will be used to fund the completion of the company's investments in Wireless Infrastructure Group and TCR and invest in further new investments during the rest of the financial year.
The offering, with an original target size of GBP350 million, was significantly oversubscribed and the final size has been set so as to ensure that the Company continues to maintain an efficient balance sheet while at
Leading international law firm, Mourant Ozannes, has advised long standing client Intertrust N.V. on its GBP435 million acquisition of Elian Group.
Netherlands-based global trust and corporate services provider, Intertrust NV, has 37 offices in 26 jurisdictions in Europe, Asia and the Middle East. Fiduciary services company Elian, which has its headquarters in Jersey, comprises 15 offices around the world.
Mourant Ozannes Partner, Simon Felton, says: "This is a positive step for Intertrust and Elian which will allow for significant growth and diversification in key jurisdictions, creating a truly global leader in their industry. Our international team of specialists worked together
Navicure, a provider of cloud-based claims management and patient payment solutions for physician practices and hospitals, has secured a strategic investment from Bain Capital Private Equity. Financial terms of the private transaction have not been disclosed.
Navicure, which is headquartered in Duluth, Georgia, will continue to be led by current CEO and founder, James M. Denny, Jr. and his executive team. They will retain a meaningful interest in the business. Selling shareholders include JMI Equity and other minority investors.
Navicure’s subscription-based software solutions help healthcare organisations of all sizes increase revenue, accelerate cash flow, and reduce the costs associated with
YFM Equity Partners has launched its new YFM Equity Partners 2016 Fund (YFMEP 2016), which will provide investors with the opportunity to participate in YFM’s future private equity investments which no longer qualify for VCT investment.
YFM has already secured GBP22 million from existing pension funds and new family office backers in the last three months and following this early success are now focussing on the next stage of fundraising. The team is looking to raise an additional GBP10-15m of private equity capital to be invested over YFMEP 2016’s two-year investment period. YFMEP 2016 complements YFM’s established VCT funds, increasing
Tikehau IM has acted as sole lead arranger of a EUR35 million unitranche denominated in USD for the acquisition of Cisbio Bioassays by Abénex.
Abénex acquires Cisbio Bioassays in a secondary LBO from Argos Soditic. Flexible unitranche financing denominated in US$ has been arranged by Tikehau IM.
Cisbio Bioassays is a French life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, Cisbio Bioassays provides creative technological solutions by partnering with the global scientific community in Codolet (France). Its portfolio of over 460 proprietary assays and reagents is
The Russian Direct Investment Fund (RDIF) is investing in a complex reconstruction of the federal M-4 Don highway in Russia, as part of its infrastructure partnership with Avtodor State Company.
The project involves complex installation work, reconstruction, maintenance, repair, structural repair and toll operation of the M-4 Don federal highway from Moscow through Voronezh, Rostov-on-Don, Krasnodar to Novorossiysk, at Section 4, Rostov – Krasnodar (section km 1091.6 – km 1319).
The company Road Investment Company LLC, created by RDIF and Avtodor to identify and implement road improvement projects in Russia, will act as the project operator. A number of
Dating app Once has secured a second wave of investment from Partech, the French venture capital firm, that supports global companies that they believe possess revolutionary concepts.
For this reason, Partech Ventures has just signed a second partnership deal with Once to invest a further one million euros in the dating app – signifying its confidence in the app’s successive business model.
The dating scene has become vastly populated in recent years and has been a challenging market for a new app to succeed in. Once attributes its strong continued growth in user sign ups to the fact that
Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics to combat drug-resistant bacterial infections, has closed a EUR22 million Series B investment round.
The round was led by new investor, Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures and Allecra's co-Founder Nicholas Benedict also participated.
The proceeds will fund Phase 2 development of AAI202, Allecra's proprietary, novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections. AAI202 is a combination of a powerful β-lactam antibiotic together with a proprietary, novel Extended Spectrum β-Lactamase Inhibitor. The combination is designed for use as
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
